PA
COGT icon

Perceptive Advisors’s Cogent Biosciences COGT Stock Holding History

Perceptive Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Hold
121,082
– – 0.07% 93
2026
Q1 		$4.66M Hold
121,082
– – 0.09% 76
2025
Q4 		$4.3M Buy
+121,082
New +$3.4M 0.08% 98
2024
Q2 		– Sell
-883,333
Closed -$5.94M – 117
2024
Q1 		$5.94M Sell
883,333
-239,625
-21% -$1.48M 0.1% 82
2023
Q4 		$6.6M Sell
1,122,958
-1,186,512
-51% -$9.09M 0.15% 70
2023
Q3 		$22.5M Sell
2,309,470
-350,000
-13% -$4.15M 0.75% 38
2023
Q2 		$31.5M Buy
2,659,470
+377,146
+17% +$4.33M 0.91% 35
2023
Q1 		$24.6M Sell
2,282,324
-925,117
-29% -$11.8M 0.73% 40
2022
Q4 		$37.1M Hold
3,207,441
– – 1.04% 28
2022
Q3 		$47.9M Buy
3,207,441
+118,469
+4% +$1.62M 1.39% 19
2022
Q2 		$27.9M Sell
3,088,972
-99,778
-3% -$681K 0.87% 27
2022
Q1 		$23.9M Hold
3,188,750
– – 0.48% 49
2021
Q4 		$27.4M Hold
3,188,750
– – 0.42% 57
2021
Q3 		$26.8M Hold
3,188,750
– – 0.39% 61
2021
Q2 		$25.9M Hold
3,188,750
– – 0.34% 74
2021
Q1 		$28M Hold
3,188,750
– – 0.35% 64
2020
Q4 		$35.8M Buy
3,188,750
+1,200,000
+60% +$13.2M 0.38% 58
2020
Q3 		$18.6M Buy
+1,988,750
New +$20.7M 0.27% 70

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Perceptive Advisors's COGT Position: Q2 2026 in Review

Perceptive Advisors held its Cogent Biosciences (COGT) position steady in Q2 2026 at 121,082 shares worth $4.69M. The position accounts for 0.07% of the portfolio, ranked #93.

Perceptive Advisors first reported a position in COGT in Q3 2020 and has held it in 18 quarters since. The position peaked at $47.9M in Q3 2022. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Perceptive Advisors held 121,082 shares of Cogent Biosciences worth $4.69M as of Q2 2026.
  • Perceptive Advisors left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up 0.07% of Perceptive Advisors's portfolio in Q2 2026, its #93 holding.
  • Perceptive Advisors first reported a position in Cogent Biosciences in Q3 2020 and has held it in 18 quarters since.
  • Perceptive Advisors's Cogent Biosciences position peaked at $47.9M in Q3 2022.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.